Alimentary Pharmacology & Therapeutics

Oral ulceration - aetiopathogenesis, clinical diagnosis and management in the gastrointestinal clinic
pp. 949-962(14)
Authors: Field, E. A.; Allan, R. B.

Ursodeoxycholic acid — adverse effects and drug interactions
pp. 963-972(10)
Authors: Hempfling, W.; Dilger, K.; Beuers, U.

Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs?
pp. 973-978(6)
Authors: Johansson, S.; Wallander, M.-A.; Ruigómez, A.; García Rodríguez, L. A.

The impact of current tobacco use on the outcome of paracetamol poisoning
pp. 979-985(7)
Authors: Schmidt, L. E.; Dalhoff, K.

How patients manage gastrointestinal symptoms after pelvic radiotherapy
pp. 987-994(8)
Authors: Gami, B.; Harrington, K.; Blake, P.; Dearnaley, D.; Tait, D.; Davies, J.; Norman, A. R.; Andreyev, H. J. N.

The utility of the ¹³C-galactose breath test as a measure of liver function
pp. 995-1002(8)
Authors: Saadeh, S.; Behrens, P. W.; Parsi, M. A.; Carey, W. D.; Connor, J. T.; Grealis, M.; Barnes, D. S.

Fistula response to methotrexate in Crohn's disease: a case series
pp. 1003-1008(6)
Authors: Mahadevan, U.; Marion, J. F.; Present, D. H.

Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel
pp. 1009-1016(8)
Authors: Parente, F.; Greco, S.; Molteni, M.; Cucino, C.; Maconi, G.; Sampietro, G. M.; Danelli, P. G.; Cristaldi, M.; Bianco, R.; Gallus, S.; Bianchi Porro, G.

Low and high doses of rabeprazole vs. omeprazole for cure of Helicobacter pylori infection
pp. 1017-1021(5)
Authors: Kositchaiwat, C.; Ovartlarnporn, B.; Kachintorn, U.; Atisook, K.

Three-day intravenous triple therapy is not effective for the eradication of Helicobacter pyloriinfection in patients with bleeding gastro-duodenal ulcer
pp. 1023-1029(7)
Authors: Romero-Gómez, M.; Martínez-Delgado, C.; Hergueta, P.; Navarro, J.-M.; Garrido-Serrano, A.; Santos, O.; Montojo, C.

Influence of tegaserod on proximal gastric tone and on the perception of gastric distension
pp. 1031-1037(7)
Authors: Tack, J.; Vos, R.; Janssens, J.; Salter, J.; Jauffret, S.; Vandeplassche, G.

Effect of a novel 5-HT₃ receptor agonist MKC-733 on upper gastrointestinal motility in humans
pp. 1039-1048(10)
Authors: Coleman, N. S.; Marciani, L.; Blackshaw, E.; Wright, J.; Parker, M.; Yano, T.; Yamazaki, S.; Chan, P. Q.; Wilde, K.; Gowland, P. A.; Perkins, A. C.; Spiller, R. C.